{"id":26,"date":"2025-11-19T23:37:03","date_gmt":"2025-11-19T22:37:03","guid":{"rendered":"https:\/\/fhucare.com\/journal-club-tijc\/"},"modified":"2026-04-17T16:35:35","modified_gmt":"2026-04-17T14:35:35","slug":"journal-club-tijc","status":"publish","type":"page","link":"https:\/\/fhucare.com\/fr\/journal-club-tijc\/","title":{"rendered":"Transdisciplinary Immunology Journal Club #TIJC"},"content":{"rendered":"\n
\"\"<\/figure>
\n

A club that brings together autoimmunity and cancer, <\/strong>two worlds linked by one bridge<\/em><\/strong>.<\/mark><\/p>\n\n\n\n

Welcome<\/strong> to the Transdisciplinary Immunology Journal Club<\/mark> <\/strong>(TIJC) \u2014 your global hub for cutting-edge immunology, cross-disciplinary insights, and career development<\/strong>. TIJC unites physicians, researchers, and students worldwide to explore breakthroughs in immunology, oncology, autoimmunity, and translational medicine.<\/p>\n\n\n\n

Open to all immunology enthusiasts ! <\/strong><\/p>\n<\/div><\/div>\n\n\n\n

Featured Sessions<\/strong><\/h3>\n\n\n\n
TITLE<\/th>SPEAKER<\/th>DATE (CET) \/ REPLAY<\/th><\/tr><\/thead>
Pathogenic role of Mucosal Associated Invariant T cells in Rheumatoid Arthritis<\/strong><\/em><\/td>Manon Lesturgie Talarek<\/td>Sept 24, 2026<\/em>
16h <\/em><\/td><\/tr>
Individualized neoantigen-targeted vaccines for lung cancer<\/strong><\/em><\/td>Joline Ingels<\/td>June 18, 2026<\/em>
16h <\/em><\/td><\/tr>
TBC<\/td>Francesca Lucibello<\/td>May 6, 2026 <\/em>
15h <\/em><\/td><\/tr>
Location-Specific T-cell Inhibitory Molecules (LoSTIMs) for targeted immunosuppression<\/em> <\/strong><\/td>James Torchia <\/td>April 23, 2026<\/em>
16h <\/em><\/td><\/tr>
Emerging Roles of Endogenous Retroelements in Immunity<\/strong>
From tissue senescence to regulation of adaptive immune responses , targeting retroelements as a strategy to mitigate immune-mediated diseases<\/em><\/td>		Nader Yatim <\/td>Watch Replay<\/a><\/td><\/tr>
Innate immune dysfunction in VEXAS syndrome<\/em><\/strong> <\/td>Paul Breillat<\/td>Watch Replay<\/a><\/td><\/tr>
Aging, Immunosenescence & Immunotherapies<\/em><\/strong> <\/td>Marie Naigeon<\/td>n\/a<\/td><\/tr>
Accelerating Cancer Immunotherapy Research<\/em><\/strong> (ACIR<\/strong>) <\/td>Ute Burkhardt & Ed Fritsch<\/td>Watch Replay<\/a><\/td><\/tr>
CD19 CAR T Cell Therapy in Multidrug Resistant Ulcerative Colitis (NEJM 2025)<\/em> <\/strong><\/td>Antoine Meyer<\/td>Watch Replay<\/a><\/td><\/tr>
High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy<\/em><\/strong> <\/td>Lucas Blanchard<\/td>Watch Replay<\/a><\/td><\/tr>
NK Cells Restrict CD8+ T Cells in Submandibular Gland via PD-1\u2013PD-L1 + irAE Colitis<\/em><\/strong> <\/td>David Zemmour<\/td>Watch Replay<\/a><\/td><\/tr>
Organoid Co-Culture Model for Systemic Anti-Tumor Immunity in Lung Cancer<\/em> <\/strong><\/td>Negaar Goudarzi<\/td>Postponed<\/td><\/tr>
Anti-PD-1 Amplifies Co-Stimulation in Melanoma-Infiltrating Th1-like Foxp3+ Tregs<\/em><\/strong> <\/td>Mikha\u00ebl Attias<\/td>Watch Replay<\/a><\/td><\/tr>
HLA Class I Peptide Polymorphisms and Antibody Specificity<\/em> <\/strong><\/td>C\u00e9dric Usureau<\/td>Watch Replay<\/a><\/td><\/tr>
Evolution of Myeloid-Mediated Immunotherapy Resistance in Prostate Cancer<\/em><\/strong><\/td>Simon Coiba<\/td>Watch Replay<\/a><\/td><\/tr>
Neoantigen Vaccines in Precision Oncology <\/em><\/strong><\/td>Adrien Mouren<\/td>Watch Replay<\/a><\/td><\/tr>
Rapid Establishment of CD8+ T Cell Dysfunction upon Tumor Antigen Encounter<\/em><\/strong><\/td>Matthieu Roulleau Dugage<\/td>Watch Replay<\/a><\/td><\/tr>
Disrupting Antitumor Immune Axis by Targeting CD206+ Macrophages<\/em><\/strong> <\/td>Marie Robert<\/td>Watch Replay<\/a><\/td><\/tr>
Revitalizing Exhausted CD8+ T Cells with Fc\u2013IL-4<\/em> <\/strong><\/td>Fran\u00e7ois-Xavier Danlos<\/td>Watch Replay<\/a><\/td><\/tr>
JAK Inhibitors and Cancer: Friend or Foe?<\/em><\/strong><\/td>Samuel Bitoun<\/td>Watch Replay<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

\u27a1 <\/mark>Follow us on LinkedIn<\/a><\/strong> to never miss a session !
\u27a1 <\/mark>Watch all Replays<\/a> below<\/strong><\/p>\n\n\n\n

\n\n\n\n

TIJC videos are hosted on YouTube. Viewing these videos implies acceptance of the YouTube API Terms of Service<\/a>.<\/p>\n\n\n\n

<\/div><\/div>

Emerging Roles of Endogenous Retroelements in Immunity #tijc<\/h2><\/div>
<\/div><\/div>

Innate immune dysfunction in VEXAS: mechanisms of inflammation and infection risk #tijc<\/h3><\/div>
<\/div><\/div>

Accelerating Cancer Immunotherapy Research (ACIR) #tijc<\/h3><\/div>
<\/div><\/div>

CD19 CAR T Cell Therapy in Multidrug Resistant Ulcerative Colitis (NEJM 2025) #tijc<\/h3><\/div>
<\/div><\/div>

HEVs : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #tijc<\/h3><\/div>
<\/div><\/div>

NK cells regulate CD8+ T cells via PD 1PD L1 & Immunotherapy Induced Colitis #tijc<\/h3><\/div>
<\/div><\/div>

CD8+ T Cell Dysfunction Begins Hours After Tumor Antigen Exposure #tijc<\/h3><\/div>
<\/div><\/div>

Evolution of myeloid mediated immunotherapy resistance in prostate cancer #tijc<\/h3><\/div>
<\/div><\/div>

Neoantigen vaccines a new era of precision medicine in oncology #tijc<\/h3><\/div>
<\/div><\/div>

Tregs & Anti PD 1 #tijc<\/h3><\/div>
<\/div><\/div>

HLA Class I Peptide Polymorphisms and Antibody Specificity #tijc<\/h3><\/div>
<\/div><\/div>

Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis #tijc<\/h3><\/div>
<\/div><\/div>

The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer #tijc<\/h3><\/div>
<\/div><\/div>

JAK Inhibitors and Cancer: Friend or Foe? #tijc<\/h3><\/div><\/div>